Puberty and Adolescence

1. Puberty and Adolescence OTHMAN MOHAMED OMAIR ALI ALFAQIRI

2. Puberty:is the process of physical changes by which a child's body becomes an adult body capable of reproduction

3. Adolescence:is the age between 10 -19 yearse transitional stage of physical and mental human development generally occurring between puberty and legal adulthood

4. PHYSIOLOGY • Puberty is initiated by hormone signals from the brain to the gonads (the ovaries and testes). • the gonads produce a variety of hormones that stimulate the growth, function, or transformation.

6. The normal puberty • Physical changes. • Hormonal changes.

7. Hair distribution Physical changes. Menstruation+ fertility Reproductive system maturation Body composition BMD

8. Physical changes. • Puberty proceeds through five stages from childhood to full maturity (P1 to P5) as described by Marshall and Tanner. • In both sexes, these stages reflect the progressive modifications of the external genitalia and of sexual hair.

9. Physical Changes for Males 1-testicular enlargement is the first physical manifestation of puberty 2-pubic hair often appears on a boy shortly after the genitalia begin to grow 3- voice change and Adams apple 4-Male musculature and body shape and Body odor and acne

10. Tanner Staging of Puberty in Males Tanner I  prepubertal (testicular volume less than 3.5 ml; small penis of 3 cm or less)[ Tanner II  testicular volume 6 ml; skin on scrotum thins, reddenss and enlarges; penis length unchanged Tanner III  testicular volume between 6 and 12 ml; scrotum enlarges further; penis begins to lengthen to about 6 cm Tanner IV  testicular volume between 12 and 20 ml; scrotum enlarges further and darkens; penis increases in length to 10 cm and circumference Tanner V  testicular volume greater than 20 ml; adult scrotum and penis of 15 cm in length

12. Breast development • The first physical sign of puberty in girls • occurring on average at about 10 years of age. • Tanner stagingof puberty.

13. Tanner Breast Development Breasts (female) Tanner I  no glandular tissue; areola follows the skin contours of the chest (prepubertal) Tanner II  breast budforms, with small area of surrounding glandular tissue; areola begins to widen Tanner III  breast begins to become more elevated, and extends beyond the borders of the areola, which continues to widen but remains in contour with surrounding breast [ Tanner IV  increased breast size and elevation; areola and papilla form a secondary mound projecting from the contour of the surrounding breast [ Tanner V  breast reaches final adult size; areola returns to contour of the surrounding breast, with a projecting central papilla. [

14. Pubic hair • second noticeable change in puberty. • usually within a few months of thelarche. • Tanner staging.

15. Tanner Pubic Staging Pubic hair (both male and female) Tanner I  no pubic hair at all (prepubertal Dominic state) [typically age 10 and younger] Tanner II  small amount of long, downy hair with slight pigmentation at the base of the penis and scrotum (males) or on the labia majora (females) [10–11.5] Tanner III  hair becomes more coarse and curly Tanner IV  adult-like hair quality, extending across pubis but sparing medial thighs [13–15]

16. UTERINE DEVELOPMENT Reproductive system maturation The Prepubertal uterus tear-drop shaped neck and isthmus accounting for up to 2/3 of the uterine volume. Craniocaudal direction without the flextion of adult . then, with the production of estrogens, it becomes pear shaped, with the uterine body increasing in length and thickness proportionately more than the cervix.

17. The mucosal surface of the vagina also changes in becoming thicker and duller pink in color. • Whitish secretions (physiologic leukorrhea ). • The ovaries usually contain small follicular cysts visible by ultrasound.

18. In prepuberty, the ovarian size volume extends from 0.3 - 0.9 TO cm3. More than 1.0 cm3 indicates that puberty has begin. During puberty, the ovarian size increases rapidly to a mean postpubertal volume of cm3. OVARY DEVLOPMENT

19. Menstruation+ fertility • menarche, and typically occurs about two years afterthelarche • The average age of menarche in girls is 11. years • The time between menstrual periods (menses) is not always regular in the first two years after menarche • Ovulationis necessary forfertility, but may or may not accompany the earliest menses • Starting of ovulation? By production of progesteron

20. Bone mineral density • 6-9 month after thelarche • 11.5 y at Ts 2-3 • BMD Peak menerlization 14-16 y. Influence by Genetic Excersise GH.

21. HORMONAL CHANGES OF PUBERTY • Gonadotropin-Releasing Hormone • •Gonadotropins • •Adrenal steroids

22. Gonadotropin-Releasing Hormone • GnRHissynthesizedandreleasedfromneuronswithinthehypothalamus. • Chromosome8. • GnRHstimulatesthesynthesisandsecretionofthegonadotropins . • GnRHissecretedinpulses . • LH ,FSH

23. Role of Gonadotropins FSH Stimulates the ovary Involved in spermatogenesis in the testes Induces receptors for LH LH Uses as substrate to produce estradiol in theca cells Stimulates testosterone synthesis by Leydig cells FSH is usually higher than LH in prepubertal stages, and this reverses in pubertal stages

24. Sex steroidsTestosterone external genitalia.Muscle growthestrogenbreast uterineadipose tissuebone mineralization epiphysiel plate

25. Abnormal puberty Precocious puberty. Delayed puberty

26. Precocious puberty the appearance of physical and hormonal signs of pubertal development at an earlier age than is considered normal. girls < 7 years. black girls 6-8 years. boys< 8 years

27. Precocious puberty can be divided into 2 distinct categories. gonadotropin-independent precocious puberty in which the presence of sex steroids is independent of pituitary gonadotropin release. GIPP gonadotropin-dependent precocious puberty involves the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis. GDPP

28. Causes 1.Constitutional or idiopathic: • In most cases of precocious puberty (90%) , no cause is found. • For some unknown reason the hypothalamus stimulates the pituitary gland to secrete its gonadotrophic hormones. • There is normal menstruation and ovulation. • Pregnancy can occur at young age.

29. Causes 2. Organic lesions of the brain: • The next common cause. • Organic lesions affecting the midbrain, hypothalamus, pineal body, or pituitary gland may lead to premature release of pituitary gonadotrophins. • Examples include traumatic brain injury, meningitis, encephalitis, brain abscess, brain tumor as glioma, craniopharyngioma, and hamartomas.

30. Causes 3. McCune-Albright syndrome. 4. Adrenal causes: (a) Hyperplasia, adenoma, or carcinoma of suprarenal cortex. Congenital adrenal hyperplasia and lead to precocious puberty in the male direction, i.e. heterosexual precocious puberty; (b) Estrogen secreting adrenal tumor which is very rare.

31. Causes 5. Ovarian causes : (a) Estrogen producing tumors as granulosa and theca cell tumor; (b) Androgen producing tumors as androblastoma; (c) Choriocarcinoma because it secretes human chorionic gonadotrophin (HCG) which may stimulate the ovaries to secrete estrogen; (d) Dysgerminomaif it secretes HCG.

32. 6. Juvenile hypothyroidism: Lack of thyroxine leads to increased production of thyroid stimulating hormone and the secretion of pituitary gonadotrophins may also be increased. 7. Drugs: • latrogenic may follow oral or local administration of estrogen. • A long course of estrogen cream used for treatment of vulvovaginitis of children may lead to breast development or withdrawal bleeding. 8. Silver syndrome: Small stature, retarded bone age and increased Gonadotrophin levels.

33. Symptoms Girls. *breast enlargement, unilateral. *Pubic and axillary hair. *Axillary odor *Menarche until 2-3 years after onset of breast enlargement. *The pubertal growth spurt occurs early in female puberty. boys *testicular enlargement *Growth of the penis and scrotum + appearance of pubic hair typically occur at least a year after testicular enlargement. *Accelerated linear growth (the pubertal growth spurt) occurs later in the course of male puberty than in female puberty

35. Signs *breast enlargement *breast diameter inc *areola darkens + thickens *nipple becomes more prominent *enlargement of the clitoris *pubic hair *deep-red color of vaginal mucosa *Mild acne *enlargement of the testes *penis growth, *reddening+thinning of the scrotum *increased pubic hair *the pubertal growth spurt, acne, *voice change, *facial hair.

36. Diagnosis of precocious puberty 1. History: • It excludes iatrogenic source of estrogen or androgen. • It differentiates between isosexual and heterosexual precocious puberty.

37. 2. Physical examination: • It diagnoses McCune-Albright syndrome. • Neurologic and ophthalmologic examinations exclude organic lesions of the brain.

38. FEMALE PRECOCIOUS PUBERTY 3. Special investigations: These are done according to the history and clinical findings and include:

39. DIAGNOSIS • X-ray examination of the hand and wrist to determine bone age. • Estrogen stimulates growth of bone but causes early fusion of the epiphysis. • So the child is taller than her peers during childhood, but she is short during adult life.

40. DIAGNOSIS b. Hormonal assay: including serum FSH, LH, prolactin, estradiol, testosterone, 17α-hydroxy progesterone, TSH, and human chorionic gonadotrophinto diagnose Choriocarcinoma.

41. DIAGNOSIS c.Ultrasonography to diagnose ovarian or adrenal tumor. d.CT or MRI : to diagnose an organic lesion of the brain, or adrenal tumor.

42. Hypothyroidism retards bone age, and is the only condition of precocious puberty in which bone age is retarded

43. Idiopathic precocious puberty: is diagnosed after excluding all other causes.

44. Treatment of precocious puberty 1. Treatment of the cause, e.g., thyroxin for hypothyroidism, removal of ovarian and adrenal tumors. 2. Incomplete forms of precocious puberty do not require treatment, as estrogen production is not increased.

45. 3. McCune-Albright syndrome • is treated with testolactone oral tablets. • The drug inhibits the formation of estrogen from its precursors, so reduces estrogen level. • The dose is 20 mg/kg body weight in 4 divided doses and increased to 40 mg/kg body weight during a 3 week interval.

46. 4. Idiopathic type is treated by explanation and reassurance and by giving one of the following drugs which inhibit the secretion of gonadotrophins: (a)Gonadotrophin releasing hormone analogues (b)Medroxyprogesterone acetate tablets (Provera tablets) (c) Danazolcapsules (d) Cyproterone acetate tablets Treatment is given till the age of 12 years (mean age of pubertal development).

47. McCune-Albright Syndrome: • The disease is found more frequently in girls. • It consists of a triad of : • Precocious puberty, • Cystic changes in bones, and • Cafe-au lait patches of the skin. • The cause of precocious puberty is autonomous production of estrogen by the ovaries. • FSH and LH levels are low. • The treatment is testolactone oral tablets which inhibit ovarian steroidogenesis.

48. Delayed Puberty Delayed puberty is indicated if no signs of puberty are observed in a girl by14 years in age and in a boy by 15 years in age Evaluation also indicated of an arrest of pubertyal maturation occurs

49. Etiology of delayed puberty 1 -Constitutional with +ve family history , short stature & normal fertility . 2 -Hypergonadotropichypogonadism Gonadal damage secondary to chemotherapy/radiation Enzyme defects in the gonads Androgen insensitivity Ovarian/testicular dysgenesis 3 -Hypogonadtropichypogonadism A male has abnormal testicles that do not produce normal levels of the sex hormone, testosterone. A female has abnormal ovaries that do not produce normal levels of sex hormone, estrogen.

50. 4- Gonadal Failure (bilateral) In these cases, circulating levels of LH & FSH are high (hypergonadotropichypogonadism) *Congenital Turner Syndrome Klinefelter’s Syndrome Complete androgen insensitivity *Acquired Chemotherapy/Radiation/Surgery Postinfectious (ie. mumps orchitis, coxsackievirus infection, dengue, shigella, malaria, varicella) Testicular torsion Autoimmune/metabolic (autoimmune polyglandular syndromes) “Vanishing Testes syndrome” “Resistant Ovaries syndomre” (gonadatropin receptor problems)